The invention provides a novel class of compounds of Formula I: (I)pharmaceutical compositions comprisingsuch compounds to treat or prevent diseases or disorders associated withabnormal or deregulated kinase activity, particularly diseasesor disorders that involve abnormal activation of c-kit, PDGFR.alpha. andPDGFR.beta.kinases.